Join our antibody development expert, VP of Business Development, Sudha Krishnan in Seattle, WA at the upcoming PBSS Forum on “Roadmap to Formulation Development of Monoclonal Antibodies and Related Proteins: From Pre-Clinical to Commercialization”.

Event Description
A symposium on formulation development of monoclonal antibodies and related proteins will explore the integrated pathway from preclinical phases to full commercialization. Sessions will include the formulation development roadmap, high-throughput screening strategies, first-in-human (FIH) formulation development, Phase 3 formulation optimization, and commercial drug product design. Experts will discuss how a deep understanding of the end-to-end development process accelerates speed to clinic, supports risk mitigation, and ensures successful technology transfer. Emphasis will be placed on balancing rapid FIH readiness with long-term stability, manufacturability, and patient usability to design robust, commercially viable formulations for therapeutic proteins.

Speakers: Bruce Kerwin, PhD (Consultant at Kerwin Biopharma Consulting); Krishnan Sampath, PhD (CTO at Dechra); Christine Siska (Scientist at Evotec); John Morgan; Robert Bailey, PhD (Consultant at Cascade Scientific Solutions; John Morgan (Partner at SeedIP)

Schedule a Meeting with Sudha at the Event